Short-acting psychedelic offers promising new treatment pathway for depression and anxiety

A new survey into the anti-depressant qualities of a short-acting psychedelic has reported extraordinarily positive improvements in well-being. The research, led by a team from Johns Hopkins University, suggests the brief duration of action seen in the drug 5-MeO-DMT makes it potentially more useful in clinical applications than longer acting psychedelics such as psilocybin and LSD.

.. Continue Reading Short-acting psychedelic offers promising new treatment pathway for depression and anxiety

Category: Science

Tags:

• Anxiety
• Depression
• Psychedelic Medicine

from New Atlas (Gizmag) https://ift.tt/2UHqmYX
via IFTTT